RhumbLine Advisers’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $65.9K | Sell |
|
|||||
|
2024
Q4 | $214K | Buy |
|
|||||
|
2024
Q3 | $402K | Sell |
|
|||||
|
2024
Q2 | $343K | Buy |
|
|||||
|
2024
Q1 | $484K | Buy |
|
|||||
|
2023
Q4 | $257K | Buy |
|
|||||
|
2023
Q3 | $193K | Buy |
|
|||||
|
2023
Q2 | $242K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $53K | Sell |
|
|||||
|
2021
Q4 | $89K | Sell |
|
|||||
|
2021
Q3 | $156K | Buy |
|
|||||
|
2021
Q2 | $218K | Buy |
|